BR100 Decreased By (-0.25%)
BR30 Decreased By (-0.64%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.83 Decreased By ▼ -0.20 (-3.32%)
BML 57.90 Increased By ▲ 5.15 (9.76%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.79 Decreased By ▼ -0.55 (-4.46%)
FCCL 53.49 Decreased By ▼ -0.40 (-0.74%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.84 Decreased By ▼ -0.19 (-1.05%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.11 Increased By ▲ 0.11 (1%)
KEL 8.02 Decreased By ▼ -0.09 (-1.11%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.40 Decreased By ▼ -0.65 (-0.74%)
NBP 184.24 Decreased By ▼ -2.24 (-1.2%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.25 Increased By ▲ 0.31 (0.78%)
PIAHCLA 26.12 Decreased By ▼ -0.05 (-0.19%)
PIBTL 17.14 Decreased By ▼ -0.18 (-1.04%)
PPL 228.73 Decreased By ▼ -4.05 (-1.74%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.54 Decreased By ▼ -0.02 (-0.03%)
SEARL 90.93 No Change ▼ 0.00 (0%)
SSGC 26.83 Decreased By ▼ -0.34 (-1.25%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.51 Decreased By ▼ -0.03 (-0.12%)
TRG 71.61 Decreased By ▼ -0.14 (-0.2%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Business & Finance

GSK Pakistan appoints Erum Shakir as new CEO

CEO of GSK Aziz ul Haq has reigned from his post citing family commitments. Erum has also served on the Board
Published February 20, 2020 Updated February 20, 2020 08:29am
  • CEO of GSK Aziz ul Haq has reigned from his post citing family commitments.
  • Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

 

Pharmaceutical giant, GlaxoSmithKline (GSK) Pakistan Limited has appointed Erum Shakir Rahim as new Chief Executive Officer (CEO) of the company, it was learnt on Thursday.  

“This is to inform the shareholders that Mr. Aziz Ul Haq Chief Executive Officer of GlaxoSmithKline Pakistan Limited has resigned to join his family in Australia. The Board of Directors has accepted his resignation with effect from March 01, 2020,” read a company’s’ notification issued at the Pakistan Stock Exchange (PSX).

The incoming CEO Erum Shakir Rahim is currently as General Manager, GSK Indonesia Pharma Emerging. The company said that Rahim “has a strong track record of success in multiple GM roles within GSK in Malaysia, Bangladesh and Indonesia.

The company informed that Erum contributed to “GSK Pakistan’s market leading position in the country with 12 percent market share and eight GSK brands in the top 20 by launching 20 new assets across several therapy areas as well as leading critical business development initiatives.”

Erum has also served on the Board of Directors in GSK Pakistan and Bangladesh in her previous roles, informed the company.

Comments

Comments are closed for this article.